Through its four specialized subsidiaries, the Group offers a broad range of high-quality generic medicines. This steadily evolving business increases the number of treatment options for patients.
The subsidiaries of the Group specialized in generics offer a range of nearly 1,500 medicines for most diseases and conditions. They employ almost 4,500 people. Most of our generic medicines are manufactured in Europe in the Group’s plants and those of our partners which meet our quality standards.
Through its specialized subsidiaries, the Group is increasingly involved in biosimilar medicines, which are an effective response to the challenge of controlling health care costs to give more patients access to innovative treatments.
Our French subsidiary distributes its medicines in France, Brazil and Nigeria. As for our Hungarian subsidiary, its markets are located mainly in Hungary, Russia, Eastern Europe and Central Europe.
Visit the websites of our main generic medicines brands:OUR GENERIC MEDICINES IN FRANCE, BRAZIL AND NIGERIA OUR GENERIC MEDICINES IN OTHER COUNTRIES